A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal Women

Phase 1 Completed 24 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.

RandomizedCrossoverOpen-labelOther

Summary

To evaluate the pharmacokinetic (PK) characteristics of GS1-144 tablets and the relative bioavailability of the two preparations in healthy postmenopausal female subjects in China.

Timeline

Start: 2025-04-30
Primary completion: 2025-07-14
Completion: 2025-07-14

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	GS1-144	Unknown	—	Oral

Indications

No indication recorded.